首页> 外文期刊>Oncogenesis. >Regulation of DNA damage repair and lipid uptake by CX 3 CR1 in epithelial ovarian carcinoma
【24h】

Regulation of DNA damage repair and lipid uptake by CX 3 CR1 in epithelial ovarian carcinoma

机译:CX 3 CR1对上皮性卵巢癌DNA损伤修复和脂质摄取的调控

获取原文
           

摘要

Failure of currently used cytotoxic chemotherapy is one of the main reasons behind high mortality from metastatic high grade serous ovarian carcinoma. We found that high expression of a receptor for fractalkine (CX3CR1) significantly correlated with shorter survival of patients with serous ovarian carcinoma treated with cytotoxic DNA damage chemotherapies, and reduction of CX3CR1 expression resulted in sensitization to several DNA damaging modalities, including x-ray radiation and cisplatin. Here, we show that CX3CR1 plays a role in double-strand DNA break response and repair by regulating expression of RAD50 by a MYC-dependent mechanism. We demonstrate that downregulation of CX3CR1 alone and in a combination with irradiation affects peritoneal metastasis in an organ-specific manner; we show that CX3CR1 regulates lipid uptake which could control omental metastasis. This study identifies CX3CR1 as a novel potential target for sensitization of ovarian carcinoma to DNA damage therapies and reduction of peritoneal carcinomatosis.
机译:当前使用的细胞毒性化学疗法的失败是转移性高级别浆液性卵巢癌高死亡率背后的主要原因之一。我们发现,高表达的fractalkine受体(CX 3 CR1)与细胞毒性DNA损伤化学疗法治疗的浆液性卵巢癌患者的较短生存期以及降低CX 3 CR1的表达导致对几种DNA损伤方式的敏感性,包括X射线辐射和顺铂。在这里,我们表明,CX 3 CR1通过依赖MYC的机制调节RAD50的表达,在双链DNA断裂反应和修复中发挥作用。我们证明CX 3 CR1单独下调以及与辐射联合下调以器官特异性方式影响腹膜转移。我们发现CX 3 CR1调节脂质的摄取,可以控制网膜转移。这项研究确定CX 3 CR1作为卵巢癌对DNA损伤疗法和减少腹膜癌变的敏感性的新型潜在靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号